SHAREHOLDER ALERT: Levi & Korsinsky Notifies Investors with Losses on Their Investment in Impax Laboratories Inc. of Class

  SHAREHOLDER ALERT: Levi & Korsinsky Notifies Investors with Losses on Their
  Investment in Impax Laboratories Inc. of Class Action Lawsuit and the
  Deadline of May 6, 2013 to Seek a Lead Plaintiff Position

Business Wire

NEW YORK -- April 16, 2013

Levi & Korsinsky announces that a class action lawsuit has been commenced in
the United States District Court for the Northern District of California on
behalf of investors who purchased Impax Laboratories Inc. (“Impax” or the
“Company”) (Nasdaq: IPXL) stock between June 6, 2011 and March 4, 2013.

For more information, click here: http://zlk.9nl.com/impax-laboratories/.

The complaint alleges that during the Class Period, the Company and certain of
its officers and directors made materially false and misleading statements in
connection with manufacturing deficiencies at the Company’s Hayward facility.
On March 4, 2013, Impax announced that the FDA had completed an inspection of
the Company’s Hayward, California facility, finding twelve problems at the
facility that the Company needed to correct. Impax also announced that due to
continuing manufacturing deficiencies, the Company did not expect to launch
its RytaryTM drug until 2014. Upon this news, shares of Impax fell 26%, to
close at $14.80 per share on March 5, 2013.

If you suffered a loss in Impax you have until May 6, 2013  to request that
the Court appoint you as lead plaintiff. Your ability to share in any recovery
doesn’t require that you serve as a lead plaintiff. To obtain additional
information, contact Joseph E. Levi, Esq. either via email at jlevi@zlk.com or
by telephone at (877) 363-5972, or visit
http://zlk.9nl.com/impax-laboratories/.

Levi & Korsinsky is a national firm with offices in New York, New Jersey, and
Washington D.C. The firm has extensive expertise in prosecuting securities
litigation involving financial fraud, representing investors throughout the
nation in securities and shareholder lawsuits. The attorneys at Levi &
Korsinsky have been appointed by numerous courts throughout the country to
serve as lead counsel on behalf of shareholders in major securities lawsuits
and have successfully recovered multimillion-dollar damages awards on behalf
of investors. For more information, please feel free to contact any of the
attorneys listed below. Attorney advertising. Prior results do not guarantee
similar outcomes.

Contact:

Levi & Korsinsky, LLP
Joseph Levi, Esq.
Eduard Korsinsky, Esq.
Tel: 212-363-7500
Toll Free: 877-363-5972
Fax: 866-367-6510
www.zlk.com